Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Microsoft makes sales chief Althoff CEO of commercial business
President of Microsoft North America Judson Althoff speaks on stage throughout We Day at KeyArena in Seattle, Washington, on April…
Microsoft to Invest $10 Billion in Japan on AI Infrastructure, Cybersecurity
The U.S. tech big is teaming up with Japanese corporations together with SoftBank. Source link
Trump Takes Aim at Chip Makers With New Plan to Throttle Imports
The administration needs home manufacturing to match imports and would impose tariffs on these corporations that don’t step up manufacturing.…